CompletedNot Applicable

In-hospital Versus After-discharge Complete Revascularization

Spain250 participantsStarted 2018-01-20

Plain-language summary

Patients with STEMI and multivessel disease in whom the culprit lesion has been successfully revascularized during prmimary PCI, will be randomized to in-hospital or after-discharge complete revascularization. The purpose of this study is to evaluate the impact of these two different strategies in terms of hospital stay.

Who can participate

Age range

18 Years – 90 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Acute onset of chest pain \<12 hours duration. * ST-segment elevation ≥ 0.1 millivolt in ≥ 2 contiguous leads, signs of a true posterior infarction or documented newly developed left bundle branch block. * Culprit lesion in a major native vessel, with successful primary PCI. * Presence of at least one non-culprit lesion more than or equal to 70% of stenosis in a vessel more than 2mm of diameter or more than or equal to 50% stenosis in proximal segments. * The patient is able to give written consent for participation in the study. Exclusion Criteria: * Pregnancy. * Significant left main stenosis. * Stent thrombosis. * Chronic total occlusion. * Severe stenosis of non-culprit vessels with distal flow less than TIMI3. * Significant non-culprit stenosis no candidate to revascularization. * Presence of valvulopathy candidate for cardiac surgery. * Cardiogenic shock status at admission. * The patient is not able to give written consent for participation in the study.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Impact in hospital stay

Timeframe: 6 months

Trial details

NCT IDNCT04743154

SponsorHospital General Universitario de Valencia

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2021-11-25

View on ClinicalTrials.gov More STEMI - ST Elevation Myocardial Infarction trials